Dyslipedemia Flashcards

1
Q

What is primary dyslipidaemia?

A

1⁰ forms are genetically determined
* Familial hypercholesterolaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is secondary dyslipidaemia?

A

2⁰ forms are consequences of other conditions / drugs
* Type 2 diabetes mellitus
* Obesity
Liver disease
* Alcoholism
* Nephrotic syndrome
* Chronic renal failure
* Hypothyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What drugs can cause 2ndary dyslipidemia?

A

isotetrinoin & protease inhibitors (! HIV tx)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Examples of HMG CoA reductase inhibitors

A

Atorvastatin (SECONDARY)
Simvastatin (PRIMARY)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Give an example of Fibrates

A

Bezafibrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the MOA of Statins?

A

Decrease LDL synthesis, and increase LDL catabolism resulting in lower LDL levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the MOA of fibrates?

A

They increase VLDL clearance and decrease VLDL synthesis, leading to low TG and VLDL, and LDL

but High HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain the MOA of Statins in depth

A

Statins inhibit HMG CoA reductase, which results in low cholesterol levels in the cell.

Low Cholesterol concentration in the cell stimulates the synthesis of LDL receptors.

Increased number of LDL receptors promote the uptake of LDL from the blood.

Low intracellular cholesterol decreases the secretion of VLDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the indications of statins?

A

Adjunct to dietary therapy for lowering LDL and total cholesterol in
dyslipidaemias where this is the major problem
* Primary and secondary prevention of cardiovascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

List short acting statins (3)

A

Simvastatin, lovastatin, pravastatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

When should statins be administered? Why?

A

Administer at night to reduce peak cholesterol synthesis in early morning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List 2 long acting statins

A

Rosuvastatin, atorvastatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Explain absorption and metabolism of statins

A

Well absorbed and extracted by the liver
* Extensive first pass hepatic metabolism via cytochrome P450 and
glucuronidation pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What type of drug is simvastatin?

A

Simvastatin is a prodrug and is converted to its active form via hepatic metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the 3 contraindications of statins?

A

Pregnancy and lactation
* Hepatic disease or elevated serum transaminases
* Drugs that inhibit CYP3A4 (protease inhibitors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

5 mild adverse effects of Statins

A

Muscle pain (myalgia)
* GI disturbance
* Raised liver enzymes
* Insomnia
* Rash

17
Q

What are serious adverse effects of statins?

A
  • Skeletal muscle damage
    (myositis – rhabdomyolysis)
    class effect and dose-related,
    more common in patients with
    lean body mass and uncorrected
    hypothyroidism (monitor
    creatinine kinase levels in blood)
  • Angioedema
18
Q

how is simvastatin excreted?

A

> 60% secreted into the bile and eliminated in the faeces

19
Q

drug interactions with simvastatin

A

Protease inhibitors
concomitant use associated with rhabdomyolysis -amlodipine & amiodarone
(simvastatin dose should not exceed 20mg daily)-diltiazem and verapamil
(simvastatin dose should not exceed 10mg daily) Fibrates and nicotinic acid

20
Q

List 3 drugs under the fibrate class.

A

Bezafibrate* (Bezalip®)
* Fenofibrate
* Gemfibrozil

21
Q

Fibrates activate which receptor?

A

PPARα (peroxisome proliferator-activated receptor α) agonists

22
Q

Explain the MOA of fibrates

A

increase transcription for genes for lipoprotein lipase, ApoproteinA1
and ApoproteinA5
* Stimulate the β-oxidative degradation of fatty acids →enhance lipoprotein
lipase ↑ hydrolysis of TG in chylomicrons and VLDL par cles → liberate FFAs
for storage in fat or for metabolism in striated muscle, increase hepatic LDL
uptake

23
Q

What are the effects of Fibrates?

A

↓ hepa c VLDL produc on & ↑hepa c LDL uptake
* ↓plasma CRP and fibrinogen levels,
* improve glucose tolerance,
* ↓ vascular smooth muscle inflamma on (inhibiting expression of
transcription factor nuclear factor KappaB )

24
Q

What is the function of APO-A1

A

ApoA1, major component of HDL particles, plays a vital role in reverse cholesterol
transport and cellular cholesterol homeostasis since its identification.

25
Q

What is the function of APO-A5

A

APOA5 mainly functions to influence plasma triglyceride levels. The first suggested
mechanism supposes that APOA5 functions as an activator of lipoprotein lipase (which is a key enzyme in triglyceride catabolism) and, through this process, enhances the
metabolism of TG-rich particles.

26
Q

Common adverse effects of Fibrates

A

GI, pruritis and rash

27
Q

What are the unusual but severe adverse effects of fibrates?

A

rhabdomyolysis cause renal failure (excretion of
muscle proteins (myoglobin))
* More common in patients with renal impairment, because of reduced protein
binding and impaired drug elimination.

28
Q

What are the 5 cautions for fibrates

A

Gall stones and gall bladder disorders
* PUD
* Hyperthyroidism
* Hypoalbuminaemic states (95% protein binding)
* Cardiovascular disease

29
Q

in which pts should fibrates be avoided? Why?

A

Avoid in patients with renal impairment and alcoholics – predisposed to
hypertriglyceridaemia, at risk for severe muscle inflammation and injury

30
Q

contraindications of fibrates

A

Severe renal and hepatic failure
* Primary biliary cirrhosis
* Pregnancy and lactation

31
Q
A